About Atrys
Atrys is a company based in Barcelona (Spain) founded in 2007. The company has 2,040 employees as of December 31, 2024. Atrys has completed 7 acquisitions, including Aerztehaus Allschwil, AxisMed and Bienzobas. Atrys offers products and services including Teleradiology, Telecardiology, Teledermatology, Diagnosis Integrado, and Smart Data. Atrys operates in a competitive market with competitors including OrigiMed, Range Bio, Nanopath, N-of-One and Coral Genomics, among others.
- Headquarter Barcelona, Spain
- Employees 2040 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Atrys Health Sa
-
Annual Revenue
$221.01 M (USD)5.54as on Dec 31, 2024
-
Net Profit
-$33.01 M (USD)30.3as on Dec 31, 2024
-
EBITDA
$36.71 M (USD)5.61as on Dec 31, 2024
-
Latest Funding Round
$270.28 K (USD), Grant
Jan 01, 2023
-
Investors
ING
& 3 more
-
Employee Count
2040
as on Dec 31, 2024
-
Investments & Acquisitions
Aerztehaus Allschwil
& 6 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Atrys
Atrys is a publicly listed company on the BME with ticker symbol ATRY in Spain, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Atrys
Atrys offers a comprehensive portfolio of products and services, including Teleradiology, Telecardiology, Teledermatology, Diagnosis Integrado, and Smart Data.
Remote radiology diagnostics for healthcare providers and patients
Remote cardiology consultations for medical professionals
Remote dermatology assessments via digital platforms
Comprehensive diagnostic solutions for oncology and general health
Data-driven tools for preventive healthcare management
Funding Insights of Atrys
Investors in Atrys
Atrys has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include ING, Deutsche Bank and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment strategies are provided across diverse asset classes and markets.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Commercial banking and insurance services are provided globally by ING.
|
Locked | Locked | Locked |
Investor details for Atrys
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Atrys
Atrys has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Aerztehaus Allschwil, AxisMed and Bienzobas.
Investment portfolio details for Atrys
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Concierge, pharmaceuticals valuation, and medical assessment services are provided.
|
Locked | Locked | 2019 | Locked | |
|
Centro Oncológico Integral en Valencia | Initia Oncología - Hospital Quirón Salud Valencia
|
Locked | Locked | 2017 | Locked | |
|
Teleradiology services are provided remotely to medical professionals in Chile.
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for Atrys
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Atrys
Detailed financials for Atrys
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Atrys Comparisons
Peer comparison for Atrys
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Atrys
Atrys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OrigiMed, Range Bio, Nanopath, N-of-One and Coral Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genetic sequencing is utilized for personalized cancer diagnostics and counseling.
|
|
| Locked | Locked | Locked |
Provider of solutions for health monitoring based on translational proteomics
|
|
| Locked | Locked | Locked |
Point-of-care molecular diagnostics for women's health are provided by Nanopath.
|
|
| Locked | Locked | Locked |
Molecular profiles are analyzed for clinical decision support in oncology.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed for personalized drug development optimization.
|
Detailed competitors of Atrys
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Atrys
Complete news archive for Atrys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atrys
Atrys was founded in 2007 and raised its 1st funding round 13 years after it was founded.
Atrys is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Isabel Lozano is the current CEO of Atrys.
As of Dec 31, 2024, the latest employee count at Atrys is 2,040.
Annual revenue of Atrys is $221.01M as on Dec 31, 2024.
Atrys is a biomedical company that has developed a new approach to the management of cancer by integrating a molecular diagnostic methodology for individual tumor phenotyping that generates information which allows a specialist to identify which clinical approach is more appropriate for a patient and to identify those who can benefit from the single-dose stereotactic body radiation therapy (SD-SBRT or Single dose radiotherapy). Apart from the oncology offering, Atrys uses its proprietary telemedicine platform to provide its services in the medical specialities of radiology, cardiology, ophthalmology and dermatology.
Atrys offers Teleradiology, Telecardiology, Teledermatology, Diagnosis Integrado, and Smart Data.
Yes, Atrys is publicly traded on BME under the ticker symbol ATRY.
Atrys has made 7 acquisitions, including Aerztehaus Allschwil, AxisMed, and Bienzobas.
Atrys has 4 investors. Key investors include ING, Deutsche Bank, European Union, and Caisse de depot et placement du Quebec.
The ticker symbol of Atrys is ATRY on BME.